ADVERTISEMENT

Capital Research buys 5% in Richter

Pharma

Capital Research & Management Co., a US investment adviser, bought 5.2% in drugmaker Richter Gedeon Nyrt.
Capital Research, based in Los Angeles, bought 975,833 shares in Richter, the Hungarian company said in a stock exchange statement, without saying when the transaction took place. The stake is valued at Ft 45.4 billion ($209 million), based on Richter's closing share price on Monday. The stock lost 0.4% to Ft 46,810. (Bloomberg)

ADVERTISEMENT

MKIK: Local business tax should be maintained Analysis

MKIK: Local business tax should be maintained

Parl't votes to phase out savings coops integration framewor... Parliament

Parl't votes to phase out savings coops integration framewor...

Roche Szolgáltató appoints P&C business partner lead Appointments

Roche Szolgáltató appoints P&C business partner lead

Budapest airport shuttle bus service expanded City

Budapest airport shuttle bus service expanded

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.